Biological characteristics of CD133+ cells in nasopharyngeal carcinoma
Open Access
- 22 April 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 30 (1) , 57-63
Abstract
Cancer stem cells are regarded as the cause of tumour formation and recurrence in nasopharyngeal carcinoma (NPC). However, ideal surface markers for stem cells in NPC remain unidentified. In the present study, we investigated the expression of CD133, Nanog and Sox2 in the nasopharyngeal carcinoma cell line CNE2 and primarily cultured NPC cells using immunofluorescence or flow cytometry. A cell population with a CD133(+) phenotype was enriched using magnetic-activated cell sorting technology. We demonstrated that CD133(+) cells exhibited a strong potential for self-renewal, proliferation and differentiation and a greater potential for in vivo tumour formation in nude mice compared to CD133(-) cells, although the percentage of CD133(+) cells was small. However, the specific marker antigens Nanog and Sox2 were simultaneously expressed in normal cancer stem cells. Our results showed that CD133 can serve as a specific surface marker for nasopharyngeal cancer stem cells.Keywords
This publication has 27 references indexed in Scilit:
- Cancer stem cells: a model in the makingCurrent Opinion in Genetics & Development, 2009
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cellsOncogene, 2008
- Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor CellsGastroenterology, 2007
- Identification of Pancreatic Cancer Stem CellsCancer Research, 2007
- A human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature, 2006
- Prospective Identification of Tumorigenic Prostate Cancer Stem CellsCancer Research, 2005
- A Tumorigenic Subpopulation with Stem Cell Properties in MelanomasCancer Research, 2005
- Identification of a cancer stem cell in human brain tumors.2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997